Democratic Republic of Congo vs Myanmar: Average cost of drugs for extensively drug-resistant tuberculosis

Democratic Republic of Congo

1,102 constant 2022 US$

in 2024

Myanmar

963 constant 2022 US$

in 2024

Democratic Republic of Congo rank

41st

Myanmar rank

43rd

Average cost of drugs for extensively drug-resistant tuberculosis over time

Democratic Republic of Congo
Myanmar

How they compare

Democratic Republic of Congo currently reports 1,102 constant 2022 US$ against 963 constant 2022 US$ in Myanmar, a difference of 139 constant 2022 US$.

That makes Democratic Republic of Congo's figure about 1.1 times Myanmar's.

The two have swapped places 3 times across 8 shared years of data; in 2017 it was Myanmar ahead.

Democratic Republic of Congo ranks 41st and Myanmar ranks 43rd of 56 countries.

Individual pages

About this data

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.